Quarterly report pursuant to Section 13 or 15(d)

Revenues from Contracts and Significant Customers (Company's product revenue) (Details)

v3.24.3
Revenues from Contracts and Significant Customers (Company's product revenue) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Product revenue, net $ 14,629 $ 15,279 $ 42,514 $ 44,405
Other revenue   19,260   19,519
Net revenue 14,629 34,752 42,555 64,567
Related Party        
Revenue - related party   31 41 97
Qbrexza        
Product revenue, net 7,583 5,865 19,435 18,038
Accutane        
Product revenue, net 3,996 4,882 15,534 15,109
Amzeeq        
Product revenue, net 1,542 2,336 3,503 4,904
Zilxi        
Product revenue, net 558 681 1,200 1,567
Other / legacy product revenue        
Product revenue, net $ 950 1,515 $ 2,842 4,787
Other Branded Revenue | Related Party        
Other revenue   19,260   19,519
Collaboration revenue        
Product revenue, net   $ 182   $ 546